Medidata Rave Alternatives

Compare Medidata Rave alternatives: EDC and clinical trial software with eConsent, ePRO, and 21 CFR Part 11–aligned controls for early-phase trials.

21 CFR Part 11–aligned · HIPAA-aligned security · No credit card required

Overview

Medidata Rave Alternatives

Medidata Rave is a widely used EDC platform for large clinical trials. Teams evaluating Rave often look for alternatives that offer faster implementation, integrated eConsent and ePRO, and pricing that fits early-phase and small-to-mid-size studies. This page is for sponsors and CROs actively comparing EDC vendors or looking for a lighter, faster option. Capture is one alternative: a single platform for EDC, eConsent, ePRO, and safety with 21 CFR Part 11–aligned controls and HIPAA-aligned security, built for speed and flexibility without enterprise overhead.

Why teams look for Medidata Rave alternatives

Rave is built for large, global trials. Many early-phase and small biotech teams find that implementation timelines and pricing are geared toward enterprise programs. If you need rapid go-live, integrated eConsent and ePRO, and 21 CFR Part 11–aligned controls without long implementation or per-seat complexity, evaluating alternatives is common. Transparent comparison criteria include implementation speed, pricing fit, eConsent/ePRO integration, and support for sponsor validation.

What to look for when comparing EDC alternatives

  • Implementation speed and time to first patient
  • Pricing model: per-seat vs. study-based; fit for early-phase and small trials
  • Integrated eConsent, ePRO, and EDC in one platform and one audit trail
  • 21 CFR Part 11–aligned controls and HIPAA-aligned security
  • Documentation and support for sponsor validation and UAT
  • Export for analysis and regulatory submissions

Why teams consider alternatives to Rave

  • Long implementation cycles and change control for early-phase studies
  • Pricing and contracts geared toward large, global trials
  • Separate or complex setup for eConsent and ePRO
  • Need for a lighter, faster option for Phase 1–2 and small biotech

Where Capture fits as an alternative

  • Single platform for EDC, eConsent, ePRO, and safety; one audit trail
  • Rapid study build and deployment; no enterprise implementation overhead
  • 21 CFR Part 11–aligned controls and HIPAA-aligned security
  • Documentation to support sponsor validation (Enterprise); pricing that scales with study size
  • Built for early-phase and mid-size trials; compare options or book a demo to evaluate fit

Related

Medidata alternativesEDC for Phase 1 trialsCompare REDCap

FAQ

Questions we hear a lot

Who is this Medidata Rave alternatives page for?
Sponsors and CROs actively comparing EDC vendors or looking for a lighter, faster option for early-phase and mid-size trials. If you need rapid go-live and integrated eConsent/ePRO without enterprise complexity, evaluating alternatives is common.
What should I compare when evaluating EDC alternatives?
Consider implementation speed, pricing fit for your study size, whether eConsent and ePRO are integrated, 21 CFR Part 11–aligned controls, and support for sponsor validation. Capture offers one platform with these attributes for early-phase and mid-size trials.
Is Capture suitable for Phase 1 and Phase 2 trials?
Yes. Capture is designed for early-phase and small-to-mid-size trials. You get EDC, eConsent, ePRO, and safety in one platform with 21 CFR Part 11–aligned controls. Many teams use Capture as an alternative to enterprise EDC for Phase 1–2.

Ready to see Capture in action?

Explore the platform with a free sandbox. No sales call required.